期刊文献+

△Np63在喉癌中的表达及意义

Expression and Significance of △Np63 in Laryngeal Carcinoma
暂未订购
导出
摘要 目的:探讨喉癌中△Np63蛋白表达及其与临床病理的关系。方法:应用免疫组化SP法检测喉癌和正常喉黏膜中△Np63蛋白的表达。结果:喉癌中△Np63的阳性表达率为75.0%,正常喉粘膜中的阳性表达率为15.0%,组间比较差异具有显著性(P<0.01)。阳性表达率与组织学分级有关(P<0.05)。结论:△Np63可能与喉癌的发生、分化和预后有关,可以作为喉鳞癌和腺癌鉴别诊断的依据。 Objective : To investigate the expression of △Np63 protein, and the possible relationship between △Np63 expression and clinicopathological indices in laryngeal carcinoma. Methods. The expression of △Np63 was detected in 40 larynx cancer tissues by immunohischemical method(sp) and 20 normal larynx tissues as control. Results, The rate of expression of △Np63 protein in laryngeal carcinoma was 75. 0% (30/40), in the normal larynx tissues was 15.0 % (3/20), the difference was significant(P〈0. 01);the positive ratio of the expression of △Np63 was significantly relate to histological differentiations of laryngeal carcinoma(P〈0.05). Conclusion.. Over expression of △Np63 may be associated with the carcinogenesis and lower differentiation and prognosis, and it is also may be a diagnostic evidence for identifying laryngeal squamous carcinoma and adenocarcinoma.
作者 成克伦
出处 《实用临床医学(江西)》 CAS 2007年第12期9-10,共2页 Practical Clinical Medicine
关键词 喉癌 △NP63 免疫组化 laryngeal carcinoma △Np63 immunohischemistry
  • 相关文献

参考文献7

二级参考文献45

  • 1Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transaetivating,death-inducing, and dominant-negative activities [J]. Mol Cell,1998, 2(3):305-316.
  • 2Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development [J]. Nature, 1999, 398:714-718.
  • 3Mills AA, Zheng B, Wang XJ, et al, P63 is a p53 homologue required for limb and epidermal morphogenesis [J]. Nature,1999, 398:708-713.
  • 4Nylander K, Coates PJ, Hall PA, et al. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions [J]. Int J Cancer, 2000, 87(3): 368-372.
  • 5Sun Y, Hegamyer G, Cheng YJ, et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma[J]. Proc Nail Acad Sci USA, 1992, 89 (14):6516-6520.
  • 6Spruck CH3rd, Tsai YC, Huang DP, et al. Absence of p53 genemutations in primary nasopharyngeal carcinomas [J]. Cancer Res, 1992, 52(17): 4787-4790.
  • 7Parsa R, Yang A, McKeon F, et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocyles [J]. J Invest Dermatol, 1999, 113:1099-1105.
  • 8Crook T, Nieholls JM,expression of dehaN-p63: Brooks, et al. High level a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma(NPC)?[J]. Oncogene, 2000,19(30):3439-3444.
  • 9Wang TY, Chen BF, Yang YC, et al. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases [J].Hum Patho, 2001, 32(5): 479-486.
  • 10Yang A,Kaghad M,Wang Y, et al. P63,aP53 homolog at 3q27 - 29,encodes mutiple prodncts with transactivating, death-inducing, and dominantnegative acticities[ J]. Mol cell. 1998,2(3) :305 - 316.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部